Primcyv + 125mg Capsule
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Palbociclib (125mg)
Overview Primcyv + 125mg Capsule
Palbociclib 125mg capsules are indicated for treating certain metastatic breast cancers (estrogen receptor-positive, HER2-negative). This medication is administered concurrently with endocrine therapy. For optimal absorption, take Palbociclib 125mg capsules with food at the same time daily, as prescribed by your physician. Dosage and frequency are individualized and may be adjusted. Strict adherence to your doctor's instructions is crucial; improper use or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue use only under your doctor's guidance. Common side effects include tiredness, alopecia, skin rash, nausea, and diarrhea. This medication can lower blood cell counts, increasing infection risk. Report any infection signs (fever, chills, weakness), bleeding, bruising, or nosebleeds to your doctor. Dizziness may occur; avoid driving or activities requiring alertness if affected. Inform your physician of any pre-existing heart, liver, or kidney conditions, or concurrent use of other medications, particularly anti-infectives, before commencing treatment. Interactions with other drugs are possible; disclose all medications to your healthcare provider. This medicine is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners during treatment.
Primary Ingredients of Primcyv + 125mg Capsule
There is no text provided to rephrase.
Uses of Primcyv + 125mg Capsule
Malignant breast tumor
Major Benefits of Primcyv + 125mg Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Primcyv 125mg capsules with food.
Common Side effects of Primcyv + 125mg Capsule:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Primcyv + 125mg Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Primcyv 125mg capsules with food.
How Primcyv + 125mg Capsule works:
Primcyv 125mg capsules are an anticancer drug that functions by blocking cyclin-dependent kinases 4 and 6 (CDK4/6). These kinases are key components in cellular signaling pathways driving cancer cell growth. By inhibiting CDK4/6, Primcyv halts the progression of the cancer cell cycle, effectively slowing tumor development. Furthermore, it specifically targets estrogen receptor-positive breast cancer cells by interfering with their cell cycle mechanisms.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Primcyv + 125mg Capsules may be unsafe; physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Taking Primcyv 125mg capsules during pregnancy poses a known risk to the fetus. Prescribing this medication during pregnancy is uncommon, reserved only for life-threatening conditions where potential benefits outweigh the clear dangers. Always seek medical advice.
Breast feedingUNSAFE
Nursing mothers should not take Primcyv 125mg capsules. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking Primcyv 125mg capsules might lead to adverse reactions that impair driving ability. Drowsiness is a possible side effect. If experienced, avoid operating vehicles or machinery.
KidneySAFE IF PRESCRIBED
Primcyv + 125mg capsules may be administered to patients with renal impairment without modification of the prescribed dosage.
LiverCAUTION
Patients with liver impairment should use Primcyv + 125mg Capsules cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Primcyv + 125mg Capsule :
NA
Facts to Know About Primcyv + 125mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Piperazine-pyridines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavioral Class | CDK Inhibitor |



